Hi Peace, You wrote;How long do you anticipate it will take to...

Hi Peace,

You wrote;

How long do you anticipate it will take to commercialise?

This passage was taken from 2013 Annual Report:

New Technological Advances: Over the past 18 months the company has invested heavily in development of new capabilities designed to ensure the company stays at the forefront of advances in the peptide-based drug discovery field. While the endosomal escape trap is one such example of a unique capability there are a number of additional technologies the company has been actively progressing that are expected to come on-line over the coming months. These include efforts to generate genetically encoded macrocyclic Phylomer libraries that promise to significantly improve the drug-like properties of hits that emerge from the various screens. Successfully delivering on these outcomes will enable the company to expand its patent portfolio further enhancing the prospects of commercialisation.

http://phylogica.com/media/articles/Investors---Financial-Reports/20131031-Annual-Report-to-Shareholders-June-2013-1138/PhylogicaAR2013_FINAL-1.pdf

If Phylogica are successful with the Endosomal Escape Trap technology (EET), then the Macrocycyclic Technology (MT) I don't think will take long at all (perhaps by the end of the year is my thoughts??). It's just a rough guess, but the first time we heard about Macrocycles was in the Edison Report back in January 2013. Just over a year has passed since then. So all up by that stage 2 years would have passed. Hopefully it will be sooner than that. What do you think?

With re to your question;

Also a question nobody here can probably answer with any accuracy but anyway what kind of cost outflow do you think it will take to integrate the macrocyclic technology into the existing platform? I'd go out on a limb and say that hasn't been accounted for with the standard $0.45M / month burn ?

I haven't had an opportunity to go back and re-read the financials over the past 12-18 months, but has the quarterly cost outflow figures increased by much (item per item) quarter to quarter? The reason I ask this is because it may give an 'indication' of the ET cost outflow figure (since work began on the new technologies) even though it won't be specific?

Tony